News articles

We have published the outcomes from the targeted consultation, roundtable and stakeholder discussions reviewing certain Authorised Prescriber (AP) scheme requirements for accessing MDMA and psilocybine.

ANDEXXA is no longer provisionally approved for use in Australia and has been removed from the Australian Register of Therapeutic Goods (ARTG).

The Prescription Medicines in Pregnancy database has been updated to include new entries and amend some existing entries.

Sponsors and manufacturers intending to export medicines and medical devices to Indonesia should be aware of new and emerging halal certification requirements under Indonesia’s Halal Product Assurance framework.

The TGA initiated targeted compliance reviews of select listed medicines containing Magnesium to verify whether sponsors had appropriate evidence to support their medicine’s exercise performance claims.

We are providing an updated statement on the IChEMS and the prohibitions relevant to chemicals such as certain PFAS chemicals, UV-328 and Dechlorane Plus